Benjamin Rush Field

Direttore/Membro del Consiglio presso USL Pharma International UK Ltd.

57 anni

Health Technology

Commercial Services

Posizioni attive di Benjamin Rush Field

Società	Posizione	Inizio	Fine
USL Pharma International UK Ltd. USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology USL Pharma International UK Ltd. operates as a holding company whose subsidiaries engages in the development of drugs for the treatment of neurological and inflammatory disorders. The company was founded on June 8, 2012 and is headquartered in London, the United Kingdom.	Direttore/Membro del Consiglio	16/04/2015	-
Proximagen Group Plc Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom.	Direttore/Membro del Consiglio	16/04/2015	-

Distribuzione geografica

Regno Unito

Posizioni

Director/Board Member

Settori

Health Technology	2
Commercial Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
USL Pharma International UK Ltd. USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology USL Pharma International UK Ltd. operates as a holding company whose subsidiaries engages in the development of drugs for the treatment of neurological and inflammatory disorders. The company was founded on June 8, 2012 and is headquartered in London, the United Kingdom.	Health Technology
Proximagen Group Plc Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom.	Commercial Services